Refractory Alveolar Soft Part Sarcoma
2 clinical trials · Condition
◉ Watch Refractory Alveolar Soft Part Sarcoma
| Record | Firm | Date |
|---|---|---|
| Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial (NCT05333458) | National Cancer Institute (NCI) | 2022-08-29 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
Track Refractory Alveolar Soft Part Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.